scispace - formally typeset
Open AccessJournal ArticleDOI

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.

Reads0
Chats0
TLDR
Cympathetic activity in patients with heart transplants or myasthenia gravis who were not being treated with cyclosporine was no different from that in Patients with essential hypertension or in normal controls, and cyclospora-induced hypertension is associated with sympathetic neural activation.
Abstract
Background. Hypertension is a frequent complication of cyclosporine-induced immunosuppression, but the underlying mechanism is unknown. In anesthetized animals, the administration of cyclosporine increases sympathetic-nerve discharge, which may contribute to hypertension. Methods. To determine whether cyclosporine-induced hypertension is accompanied by sustained sympathetic neural activation in patients, we recorded sympathetic action potentials using intraneural microelectrodes (in the peroneal nerve) in heart-transplant recipients receiving azathioprine and prednisone alone (n = 5) or in combination with cyclosporine (n = 14). We performed the same studies in eight patients with myasthenia gravis who were receiving cyclosporine and eight who were not, in five patients with essential hypertension, and in nine normal controls. Results. Heart-transplant recipients receiving cyclo-sporine had higher mean arterial blood pressure (±SE) than those not receiving cyclosporine (112±3 vs. 96±4 mm Hg; P<0....

read more

Content maybe subject to copyright    Report

Virginia Commonwealth University
VCU Scholars Compass
27*52&0*).(.2*8'0.(&7.326 *473+27*52&0*).(.2*

CYCLOSPORINE-INDUCED SYMPATHETIC
ACTIVATION AND HYPERTENSION AFTER
HEART-T$NSPLANTATION
Urs Scherrer
University of Texas Southwestern Medical Center at Dallas
Susan F. Vissing
University of Texas Southwestern Medical Center at Dallas
Barbara J. Morgan
University of Texas Southwestern Medical Center at Dallas
See next page for additional authors
3003:7-.6&2)&)).7.32&0:35/6&7 -@46(-30&56(314&669(8*)8.271*)%48'6
&573+7-* *).(.2*&2)*&07- (.*2(*6311326
531?**:2,0&2)3852&03+*).(.2* (-*55*5"#.66.2, 35,&2*7&0$ 
" $!!!#!$! !!!> !!#30
&,*34;5.,-7=&66&(-86*@6*).(&0 3(.*7;*45.27*):.7-4*51.66.32
?.657.(0*.6'538,-773;38+35+5**&2)34*2&((*66';7-**473+27*52&0*).(.2*&7#" (-30&56314&667-&6'**2&((*47*)+35.2(086.32
.227*52&0*).(.2*8'0.(&7.326';&2&87-35.<*)&)1.2.675&7353+#" (-30&56314&6635135*.2+351&7.3240*&6*(327&(7
0.'(314&669(8*)8
3:203&)*)+531
-@46(-30&56(314&669(8*)8.271*)%48'6

Authors
"56 (-*55*5 86&2#.66.2,&5'&5&35,&280.&300.26.(-&5) !.2)&00 7*9*6.2,*7*5
&26325&13)3-&27;&2)32&0)#.(735
?.6&57.(0*.6&9&.0&'0*&7#" (-30&56314&66 -@46(-30&56(314&669(8*)8.271*)%48'6

The New England Journal of Medicine
Downloaded from nejm.org at VIRGINIA COMMONWEALTH UNIV on January 27, 2015. For personal use only. No other uses without permission.
Copyright © 1990 Massachusetts Medical Society. All rights reserved.

The New England Journal of Medicine
Downloaded from nejm.org at VIRGINIA COMMONWEALTH UNIV on January 27, 2015. For personal use only. No other uses without permission.
Copyright © 1990 Massachusetts Medical Society. All rights reserved.

The New England Journal of Medicine
Downloaded from nejm.org at VIRGINIA COMMONWEALTH UNIV on January 27, 2015. For personal use only. No other uses without permission.
Copyright © 1990 Massachusetts Medical Society. All rights reserved.

Citations
More filters
Journal ArticleDOI

A reversible posterior leukoencephalopathy syndrome

TL;DR: Reversible, predominantly posterior leukoencephalopathy may develop in patients who have renal insufficiency or hypertension or who are immunosuppressed and the findings on neuroimaging are characteristic of subcortical edema without infarction.
Journal ArticleDOI

Sympathetic neural mechanisms in obstructive sleep apnea.

TL;DR: It is concluded that patients with obstructive sleep apnea have high sympathetic activity when awake, with further increases in blood pressure and sympathetic activity during sleep, which are attenuated by treatment with CPAP.
Journal ArticleDOI

Sympathetic overactivity in patients with chronic renal failure.

TL;DR: Chronic renal failure may be accompanied by reversible sympathetic activation, which appears to be mediated by an afferent signal arising in the failing kidneys.
Journal ArticleDOI

Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

TL;DR: Systemic features in PRES appear to render strong support for the older theory of vasoconstriction coupled with hypoperfusion as the mechanism, including supporting evidence and current available imaging/clinical data related to the conditions that develop PRES.
Journal ArticleDOI

Sympathetic Nerve Activity in End-Stage Renal Disease

TL;DR: Increased SNA is observed in renal transplant recipients with diseased native kidneys at a level not significantly different from chronic hemodialysis patients, and seems to be mediated by signals arising in the native kidneys that are independent of circulating uremia related toxins.
References
More filters
Journal ArticleDOI

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.

TL;DR: There is marked regional variation, inapparent from measurements of plasma norepinephrine concentration, in sympathetic nerve activity in patients with congestive heart failure.
Journal ArticleDOI

Cyclosporine-associated chronic nephropathy

TL;DR: It is concluded that long-term cyclosporine therapy may lead to irreversible and potentially progressive nephropathy and should be used with restraint and caution until ways are found to mitigate its nephrotoxicity.
Journal ArticleDOI

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

TL;DR: Whether sympathetic nerve activity is increased in patients with heart failure and whether plasma norepinephrine levels correlate with levels of mSNA in heart failure are determined and microneurography is used to directly record sympathetic nerve action to muscle.
Journal ArticleDOI

Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans.

TL;DR: Data indicate that muscle sympathetic nerve activity is increased by stimulation of chemically sensitive muscle afferents during static exercise in humans.
Related Papers (5)